We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hutchmed (china) Limited | LSE:HCM | London | Ordinary Share | KYG4672N1198 | ORD USD0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 310.00 | 307.00 | 310.00 | 314.00 | 303.00 | 311.00 | 17,440 | 16:35:23 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 838M | 100.78M | - | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
17/10/2016 15:34 | US institutions won't buy because one of the attractions of biotech is that if a company gets lucky and discovers something big,it will nine times out of ten get taken over!This stock is takeover proof. | steeplejack | |
13/10/2016 08:18 | hmmmm yes! He still has a large holding and maybe he sold to fund something such as a house purchase but the price drift is frustrating, especially the fact we are down 16% on NASDAQ since the IPO. Almost no U.S. institutional Investors on board (similar to Beigene). My conclusion is the big U.S. Specialist Funds will not invest because we are a Chinese Company, albeit controlled by a Hong Kong conglomerate. | nerdofsteel | |
12/10/2016 13:53 | Non- exec share sale.He's got bored like the rest of us. | steeplejack | |
11/10/2016 14:27 | Lots of deals taking place, the latest one is Shire to take over Radius. We must get pipeline news shortly... | nerdofsteel | |
09/10/2016 16:28 | surely due some news on the pipeline by now | nerdofsteel | |
23/9/2016 07:08 | got excited there, someone else posting on the board, only to find them snoring! Interesting that the words shortly, imminently and soon have an entire new meaning of the words compared to their normal use. | nerdofsteel | |
22/9/2016 07:39 | Zzzz Zzzz zzz | steeplejack | |
21/9/2016 15:19 | Big news due very shortly eg. in the next 6 months!! | nerdofsteel | |
13/9/2016 11:24 | Lots of news due, mainly on the pipeline, especially Savolitinib and Fruquintinib. I wonder how the initial presentations and meetings went with the FDA? | nerdofsteel | |
17/8/2016 09:06 | good for me, I continue to buy but I get your point | nerdofsteel | |
15/8/2016 09:56 | Right shoulder of h+s formation?looks like it, not good if so | tsmith2 | |
09/8/2016 10:06 | Mr Nash's family buy yet again, clearly he knows how big we will be in the coming decade | nerdofsteel | |
04/8/2016 08:08 | hxxp://stocktwits.co | nerdofsteel | |
03/8/2016 13:53 | Anyone come across any US-based discussion forums for HCM? | nahoon | |
03/8/2016 12:07 | True but the tide appears to be turning.The biotech investment trusts are well off their lows.This stock is still suffering the after effects of a poorly handled ADR issue.Certainly as far as UK holders are concerned. | steeplejack | |
03/8/2016 10:46 | Then again Biotech & Biopharma have been out of favour so far this year in the U.S. markets | nerdofsteel | |
03/8/2016 08:46 | Zzzzzz zzzzzz zzzz | steeplejack | |
02/8/2016 18:40 | Brilliant Results, American market still sleeping | nerdofsteel | |
02/8/2016 07:02 | Indeed, and the American market seems to be in a deep sleep Let's hope the H1 results are well received today | nerdofsteel | |
01/8/2016 08:56 | Very good news this morning though you would never guess it from the share price. | miti 1000 | |
30/7/2016 13:53 | Very much Looking forward to H1 results on Tuesdy | nerdofsteel | |
21/6/2016 11:15 | interesting, and Savolitinib in NSLC alone could result in global sales attributable to Chi-Med if circa $180m pa. peak sales | nerdofsteel | |
09/6/2016 10:41 | Thanks nerdsofsteelTheir valuation translates into about £26 | nfs |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions